Specific focus on clinical cardiovascular pharmacology
The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.
It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.
Editor-in-Chief: Stefan Agewall FESC, NO
Current volume: 3 (year 2017)
Issues per subscription: 4
Access your online Journal
Connect with us on Twitter using @ESC_Journals
Non ESC Members
Members of Working Group on Cardiovascular Pharmacotherapy
Print + Online
Not an ESC member yet? Join now
Already an ESC member? Order now
New issue alert – Table of content
New advance articles alert
Before being published, all manuscripts go through double-blinded peer review by experienced international experts.
Submit your manuscript
If you would like more information, read the authors instructions
If you would like more information on reprints, rights/permissions and advertising, visit Publisher website.
Looking for answers? Check here
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved